Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol

Inclusion Criteria

• •1. meet the aforementioned diagnostic criteria for trigeminal ZAP, with a disease duration of 1 to 3 months;
• •2. have a visual analog scale (VAS) score of 4 points ≤ VAS ≤ 7 points;
• •3. be between 18 and 85 years old, regardless of gender;
• •4. have clear consciousness, the ability to distinguish pain, and complete basic communication;
• •5. voluntarily participate in the study, sign a written informed consent form, and fully understand the plan.
• •2. have concomitant herpes zoster on the trunk or extremities, or other special types of herpes zoster like meningeal herpes zoster or visceral herpes zoster;
• •3. are pregnant or lactating patients;
• •4. are allergic to pregabalin or acupuncture stimulation;
• •5. have severe organ damage, cognitive dysfunction, mental disorder, aphasia, or other serious diseases that hinder cooperation with treatment;
• •6. have severe skin diseases;
• •7. have a pacemaker;
• •8. have been or are currently participating in other clinical studies within the past 3 months.